It's often difficult to manage patients with this skin inflammation, but new research identifies a target that existing medications are able to address. Constant itchy, painful bumps, scaly arms and ...

PITTSBURGH, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella" or the "Company"), a clinical-stage biotechnology company focused on innovative therapies for ...

Oral Lichen Planus: Causes, Symptoms, Treatment, and Prevention: By Anjali Srivastava Oral Lichen Planus is a long-term inflammatory condition that affects the soft tissues inside the mouth, often ...

Please provide your email address to receive an email when new articles are posted on . The standardized overall prevalence rate of lichen planus was 0.15%. Among those treated with systemic ...

PITTSBURGH, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet needs, ...

Constant itchy, painful bumps, scaly arms and legs, and damaged nails make lichen planus an inflammatory skin disease that's both frustrating and painful for patients trying to keep their quality of ...

LP-310 shows significant improvements in pain and inflammation for oral lichen planus, with favorable safety results in Phase 2a trial. Lipella Pharmaceuticals has announced promising results from its ...

The "Clinical Snapshot" series provides a concise examination of a clinical presentation including history, treatment, patient education, and nursing measures. Using the format here, you are invited ...

Please provide your email address to receive an email when new articles are posted on . At week 28, 88% of patients treated with combination therapy achieved 75% disease severity reduction vs. 47% on ...

Once leukoplakia has been ruled out, what are the preferred treatments for oral lichen planus? —Chris Moran, MSN, CRNP, Southampton, Pa. Once the diagnosis has been confirmed, therapy includes medical ...